Integration of Lp(a)Testing Across Health Care Organizations

EP: 1.Decoding Atherogenic Lipoproteins: Unraveling the Role of LDL and Lp(a)

EP: 2.Unveiling Hidden Risks: The Case for Lp(a) Testing

EP: 3.Lp(a) Genetic Patterns

EP: 4.Insights From the Lp(a) HERITAGE Study

EP: 5.Lp(a) Ethnicity and Gender Risks

EP: 6.Unveiling Cardiovascular Disparities in Lp(a)

EP: 7.Lp(a) Screening in ASCVD: Clinical Integration

Now Viewing

EP: 8.Integration of Lp(a)Testing Across Health Care Organizations

EP: 9.A Look to The Future of Lp(a) Management

EP: 10.Actionable Insights for Health Care Decision Makers on Lp(a) Testing

This is a video synopsis/summary of an Insights involving Michael D. Shapiro, DO, and Jaime Murillo, MD.

Shapiro highlights the need for a coordinated approach between primary care and cardiology to leverage emerging lipoprotein(a) (Lp[a])-lowering therapies. He emphasizes universal screening in primary care to identify individuals with high Lp(a), who can then be referred to cardiology for consideration of novel treatments. Shapiro advocates for streamlined electronic health record systems and integrated health care networks to facilitate this collaborative approach. Health care systems are encouraged to invest in the necessary infrastructure for coordinated Lp(a) testing, stratification, referral, and treatment.

Murillo outlines 6 ways to effectively incorporate Lp(a) testing into clinical practice. He emphasizes guideline adherence, clinician education, community empowerment, and proactive business environments conducive to prevention. Murillo underscores the importance of partnerships with communities, advocacy groups, and health care systems to address individuals’ needs before adverse events occur.

Discussing the potential implications of making Lp(a) testing a key quality measure, Murillo emphasizes the proactive approach to prevention. Identifying individuals at risk allows for early intervention with lifestyle changes and emerging therapies. He stresses the importance of Lp(a) testing as a quality measure to address gaps in nontraditional risk factors, emphasizing prevention over reactive measures in health care.

Video synopsis is AI-generated and reviewed by AJMC^® editorial staff.